2-(1-octynyl)adenosine has been researched along with adenosine-3',5'-cyclic phosphorothioate in 1 studies
Studies (2-(1-octynyl)adenosine) | Trials (2-(1-octynyl)adenosine) | Recent Studies (post-2010) (2-(1-octynyl)adenosine) | Studies (adenosine-3',5'-cyclic phosphorothioate) | Trials (adenosine-3',5'-cyclic phosphorothioate) | Recent Studies (post-2010) (adenosine-3',5'-cyclic phosphorothioate) |
---|---|---|---|---|---|
23 | 0 | 3 | 507 | 0 | 47 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kimura, J; Matsuoka, I; Nakanishi, H; Ohkubo, S; Ono, T | 1 |
1 other study(ies) available for 2-(1-octynyl)adenosine and adenosine-3',5'-cyclic phosphorothioate
Article | Year |
---|---|
Effects of YT-146 [2-(1-octynyl) adenosine], an adenosine A2A receptor agonist, on cAMP production and noradrenaline release in PC12 cells.
Topics: Adenosine; Adenosine Triphosphate; Alkynes; Animals; Bucladesine; Calcimycin; Calcium; Carbachol; Cholinergic Agonists; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Ionophores; Isoquinolines; Membrane Potentials; Norepinephrine; PC12 Cells; Potassium Chloride; Purinergic P1 Receptor Agonists; Rats; Receptor, Adenosine A2A; Sulfonamides; Thionucleotides; Tritium; Vasodilator Agents | 1998 |